Clinical Trial Update: Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating different durations of adjuvant anastrozole therapy after 2 to 3 years of tamoxifen in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED